在没有可检测的炎症的情况下,内源生成的荷兰类型的Aβ非纤维聚合物调节不良的突触前神经传递
bioRxiv : the preprint server for biology
|March 10, 2025
概括
具有APP突变的转基因小鼠积累非纤维化粉样β聚合物 (NFA-Aβ),导致学习缺陷和突触功能障碍,而不会形成斑块. 消除纤维细胞和NFA-Aβ可能对降低毒性至关重要.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 转基因小鼠模型对于研究阿尔茨海默病的发病过程至关重要.
- 粉样蛋白前体蛋白 (APP) 突变可以改变粉样β (Aβ) 聚合途径.
- 非纤维状Aβ聚合物 (NFA-Aβ) 与神经毒性有关.
研究的目的:
- 研究APP突变对缺乏粉样斑块的小鼠学习,突触功能和分子通路的影响.
- 描述NFA-Aβ在老化APP转基因小鼠中的积累和影响.
主要方法:
- 使用了具有特定突变 (E693Q) 的 APP 转基因小鼠,该突变可以防止纤维的形成.
- 使用A11免疫组织化学和循环D,L-α--FITC显微镜检测NFA-Aβ.
- 通过电生理学记录评估突触功能 (肌痛后的强化,突触疲劳,囊泡补充).
- 在激发性神经元上进行单细胞RNA测序和微质转录分析.
- 在荷兰小鼠中测量了线粒体复合体I活动.
主要成果:
- APP转基因小鼠表现出与衰老相关的学习缺陷,并积累了NFA-Aβ.
- 前突触终端显示了年龄相关的生理异常.
- 刺激性神经元表现出改变的转录基因特征,特别是在蛋白质翻译和氧化酸化途径中.
- 在荷兰小鼠中,线粒体综合体I活动减少.
- 在微质转录分析中没有发现炎症的证据.
结论:
- APP突变可以通过NFA-Aβ积累导致与年龄相关的认知衰退和突触功能障碍,独立于斑块形成.
- 改变的神经元代谢,包括氧化酸化受损,有助于观察到的缺陷.
- 针对纤维状和非纤维状Aβ物种可能是对阿尔茨海默病有效治疗干预的必要.
相关概念视频
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Alzheimer's Disease: Overview
412
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
412


